VDR and neoplasm: Previous in vitro studies on several tumor types, including CRC, have shown that the vitamin D active form, 1α,25-dihydroxyvitamin D3 [1,25(OH)2D3] (calcitriol), is able to promote cell differentiation and inhibit tumor invasion and proliferation upon binding to its receptor VDR [5].